Suspected black cohosh hepatotoxicity-Causality assessment versus safety signal

Maturitas

Volumn 64, Issue 2, 2009, Pages 139-140

  Mahady, Gail ^a   Low Dog, Tieraona ^b   Sarma, Dandapantula N ^c   Giancaspro, Gabriel I ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNITED STATES PHARMACOPEIA   (United States)

Author keywords

Black cohosh; Hepatotoxicity; USP

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT;

DIET SUPPLEMENTATION; HUMAN; LETTER; LIVER TOXICITY; PATIENT ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; RISK ASSESSMENT;

CAUSALITY; CIMICIFUGA; DIETARY SUPPLEMENTS; DRUG LABELING; DRUG-INDUCED LIVER INJURY; HUMANS; UNITED STATES;

CIMICIFUGA DAHURICA;

EID: 70349748782     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.08.015     Document Type: Letter

References (12)

1. Teschke R., Bahre R., Genthner A., et al. Suspected black cohosh hepatotoxicity-challenges and pitfalls of causality assessment. Maturitas (2009) PMID: 19586731. [Epub ahead of print]
2. Mahady G., Low Dog T., Barrett M.L., et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 15 July-August (4 Pt 1) (2008) 628-638
3. Vannacci A., Lapi F., Gallo E., et al. A case of hepatitis associated with long-term use of Cimicifuga racemosa. Altern Ther Health Med 15 3 (2009) 62-63
4. Pierard S., Coche J.C., Lanthier P., et al. Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Eur J Gastroenterol Hepatol 21 8 (2009) 941-945
5. Gardiner P., Sarma D.N., Low Dog T., et al. The state of dietary supplement adverse event reporting in the United States. Pharmacoepidemiol Drug Saf 17 10 (2008) 962-970
6. USP Revises Admission Criteria and Safety Classification for Dietary Supplements. Available at: http://www.usp.org/USPNF/notices/USPRevisedAdmissionCriteria.html. Posted: April 10, 2009.
7. Agbabiaka T.B., Savović J., and Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf 31 1 (2008) 21-37
8. Rochon J., Protiva P., Seeff L.B., et al. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 48 4 (2008) 1175-1183
9. EMEA: Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). Available at: http://www.emea.europa.eu/pdfs/human/hmpc/26925806en.pdf.
10. MHRA action on safety concerns over black cohosh and liver injury. Press release. July 18, 2006. Available at: http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON2024116?ssSourceNodeId=663.
11. Natural Health Products Directorate. Black cohosh; 2007. Available at: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodnatur/mono_cohosh-grappes_e.pdf.
12. Australian Therapeutic Goods Administration Statement. New labeling and consumer information for medicines containing black cohosh (Cimicifuga racemosa); 2006. Available at: http://www.tga.gov.au/cm/0705blkcohosh.htm.